FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3031411696> ?p ?o ?g. }

• W3031411696 endingPage "102734" @default.
• W3031411696 startingPage "102734" @default.
• W3031411696 abstract "Catalonia requires decentralized and simplified strategies for the diagnosis of viremic HCV infection among people who inject drugs (PWID). We aimed to perform a direct comparison of the diagnostic performance between two, single-step strategies for the screening and diagnosis of viremic HCV infection in PWID attending a drug consumption room (DCR) in Barcelona: i) on-site HCV-RNA testing using the point-of-care test (PoCT) Xpert HCV VL Fingerstick; and ii) on-site dried blood spots (DBS) collection for HCV-RNA testing at the laboratory (in-house assay). Additionally, we aimed to assess participants’ preferences in receiving HCV-RNA testing results and feasibility of same-day delivery of PoCT results. The real-world, clinical performance of these two strategies was established in comparison with the reference method (HCV viral load testing with the Xpert HCV Viral Load assay at the laboratory from venous plasma collected at the DCR). HCV genotypes/subtypes and HIV status were also determined by sequencing and serology, respectively. A questionnaire including preferences regarding the delivery of test results was administered. The prevalence of HCV-RNA was 63.0% (of which 25.8% were co-infected with HIV). The RNA-PoCT showed a sensitivity of 98.4% for detectable viral loads (>4 IU/mL) and of 100% for quantifiable viral loads (≥10, ≥1000 and ≥3000 IU/mL). For the DBS-based assay, a sensitivity of 93.7% was obtained for detectable viral loads, 96.7% for the quantifiable ≥10 IU/mL threshold, and 98.3% for both the quantifiable ≥1000 and ≥3000 IU/mL thresholds. No significant differences were detected between the sensitivity values of these two strategies, and the specificity was 100% in both cases. Half of the participants preferred to receive the HCV-RNA result on the same day, and 80% of participants received their RNA-PoCT results on the same day. Both the HCV-RNA PoCT and the DBS-based assay are highly reliable tools for the simplified diagnosis of viremic HCV infection among current PWID. These strategies allow for on-site sample collection and delivery of test results, facilitating decentralized care in harm reduction services." @default.
• W3031411696 created "2020-06-05" @default.
• W3031411696 creator A5000519767 @default.
• W3031411696 creator A5000633500 @default.
• W3031411696 creator A5013661715 @default.
• W3031411696 creator A5027483552 @default.
• W3031411696 creator A5038302869 @default.
• W3031411696 creator A5041340102 @default.
• W3031411696 creator A5060954667 @default.
• W3031411696 creator A5065916148 @default.
• W3031411696 creator A5074701677 @default.
• W3031411696 creator A5090877463 @default.
• W3031411696 creator A5091620489 @default.
• W3031411696 date "2020-06-01" @default.
• W3031411696 modified "2023-10-18" @default.
• W3031411696 title "Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain" @default.
• W3031411696 cites W2099536639 @default.
• W3031411696 cites W2171241657 @default.
• W3031411696 cites W2185218296 @default.
• W3031411696 cites W2254380230 @default.
• W3031411696 cites W2307893103 @default.
• W3031411696 cites W2549609522 @default.
• W3031411696 cites W2581165030 @default.
• W3031411696 cites W2605906203 @default.
• W3031411696 cites W2743338523 @default.
• W3031411696 cites W2765961824 @default.
• W3031411696 cites W2766704400 @default.
• W3031411696 cites W2767120416 @default.
• W3031411696 cites W2789574679 @default.
• W3031411696 cites W2795927900 @default.
• W3031411696 cites W2804577326 @default.
• W3031411696 cites W2840933791 @default.
• W3031411696 cites W2884128589 @default.
• W3031411696 cites W2894269033 @default.
• W3031411696 cites W2898222507 @default.
• W3031411696 cites W2898580126 @default.
• W3031411696 cites W2899242242 @default.
• W3031411696 cites W2909795031 @default.
• W3031411696 cites W2914561153 @default.
• W3031411696 cites W2919762750 @default.
• W3031411696 cites W2928439338 @default.
• W3031411696 cites W2936328581 @default.
• W3031411696 cites W2937892391 @default.
• W3031411696 cites W2946011915 @default.
• W3031411696 cites W2956761715 @default.
• W3031411696 cites W2969730899 @default.
• W3031411696 cites W2970505078 @default.
• W3031411696 cites W2978862152 @default.
• W3031411696 cites W2984818370 @default.
• W3031411696 cites W2991224630 @default.
• W3031411696 doi "https://doi.org/10.1016/j.drugpo.2020.102734" @default.
• W3031411696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32470849" @default.
• W3031411696 hasPublicationYear "2020" @default.
• W3031411696 type Work @default.
• W3031411696 sameAs 3031411696 @default.
• W3031411696 citedByCount "32" @default.
• W3031411696 countsByYear W30314116962020 @default.
• W3031411696 countsByYear W30314116962021 @default.
• W3031411696 countsByYear W30314116962022 @default.
• W3031411696 countsByYear W30314116962023 @default.
• W3031411696 crossrefType "journal-article" @default.
• W3031411696 hasAuthorship W3031411696A5000519767 @default.
• W3031411696 hasAuthorship W3031411696A5000633500 @default.
• W3031411696 hasAuthorship W3031411696A5013661715 @default.
• W3031411696 hasAuthorship W3031411696A5027483552 @default.
• W3031411696 hasAuthorship W3031411696A5038302869 @default.
• W3031411696 hasAuthorship W3031411696A5041340102 @default.
• W3031411696 hasAuthorship W3031411696A5060954667 @default.
• W3031411696 hasAuthorship W3031411696A5065916148 @default.
• W3031411696 hasAuthorship W3031411696A5074701677 @default.
• W3031411696 hasAuthorship W3031411696A5090877463 @default.
• W3031411696 hasAuthorship W3031411696A5091620489 @default.
• W3031411696 hasConcept C126322002 @default.
• W3031411696 hasConcept C134018914 @default.
• W3031411696 hasConcept C142462285 @default.
• W3031411696 hasConcept C142724271 @default.
• W3031411696 hasConcept C159047783 @default.
• W3031411696 hasConcept C159654299 @default.
• W3031411696 hasConcept C203014093 @default.
• W3031411696 hasConcept C2776597655 @default.
• W3031411696 hasConcept C2777580121 @default.
• W3031411696 hasConcept C3013748606 @default.
• W3031411696 hasConcept C45189115 @default.
• W3031411696 hasConcept C51915194 @default.
• W3031411696 hasConcept C54355233 @default.
• W3031411696 hasConcept C555293320 @default.
• W3031411696 hasConcept C64841741 @default.
• W3031411696 hasConcept C71924100 @default.
• W3031411696 hasConcept C86803240 @default.
• W3031411696 hasConceptScore W3031411696C126322002 @default.
• W3031411696 hasConceptScore W3031411696C134018914 @default.
• W3031411696 hasConceptScore W3031411696C142462285 @default.
• W3031411696 hasConceptScore W3031411696C142724271 @default.
• W3031411696 hasConceptScore W3031411696C159047783 @default.
• W3031411696 hasConceptScore W3031411696C159654299 @default.
• W3031411696 hasConceptScore W3031411696C203014093 @default.
• W3031411696 hasConceptScore W3031411696C2776597655 @default.
• W3031411696 hasConceptScore W3031411696C2777580121 @default.

• next